wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33434284-021AAEA1-06E8-49A4-AEF3-305A314441FA
Q33434284-021AAEA1-06E8-49A4-AEF3-305A314441FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33434284-021AAEA1-06E8-49A4-AEF3-305A314441FA
A phase I, open-label, dose-escalation, multicenter study of the JAK2 inhibitor NS-018 in patients with myelofibrosis
P2860
Q33434284-021AAEA1-06E8-49A4-AEF3-305A314441FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33434284-021AAEA1-06E8-49A4-AEF3-305A314441FA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5830150003b52b1115047dfd6e98a247b44a0dfc
P2860
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.